Candel Therapeutics, Inc. ( CADL) - Key Metrics
CADL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.52 | -$0.23 | -$0.23 |
| 2026Q1 | $0 | -$0.14 | -$0.29 | -$0.30 |
| 2025Q4 | $0 | -$0.54 | -$0.19 | -$0.20 |
| 2025Q3 | $0 | -$0.21 | -$0.19 | -$0.19 |
| 2025Q2 | $0 | -$0.09 | -$0.17 | -$0.17 |
CADL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.95 |
| 2026Q1 | 0% | -8.75 |
| 2025Q4 | 0% | -2.62 |
| 2025Q3 | 0% | -6.07 |
| 2025Q2 | 0% | -13.59 |
CADL
Price: $10.44
52 week price:
Earnings Per Share: -1.46 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 14500
Market Capitalization: 936.4 million